Effect of Cardiac Resynchronization on Morbidity and Mortality of Diabetic Patients With Severe Heart Failure
Open Access
- 1 March 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (3), 722-724
- https://doi.org/10.2337/dc06-2035
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Predictors of mortality and morbidity in patients with chronic heart failureEuropean Heart Journal, 2005
- Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting StentsCirculation, 2005
- Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failureAmerican Heart Journal, 2005
- Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HFAmerican Heart Journal, 2005
- Impact of diabetes mellitus on long-term survival in patients with congestive heart failureEuropean Heart Journal, 2004
- Cardiac Resynchronization Therapy Improves Heart Rate Variability in Patients with Symptomatic Heart FailureCirculation, 2003
- Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialEuropean Heart Journal, 2000
- Diabetes mellitus and congestive heart failureEuropean Heart Journal, 1999
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979